EU PV for Retapamulin-Prescribing

NCT01153828 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Impetigo

Interventions

DRUG: Retapamulin
DRUG: Co-prescription of retapamulin and topical mupirocin
DRUG: Co-prescription of retapamulin and topical fusidic acid

Sponsor

GlaxoSmithKline